
Obesity, Innovation, Action: The WHO Roadmap for GLP-1 Therapies πππ
Dr RR Baliga's "Got Knowledge Doc" Podkast
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
π New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care ππ
The latest JAMA report highlights a pivotal moment in global health: the WHO's evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide, this chronic, relapsing disease demands integrated, equitable, lifelong care.
The guidance underscores two essentials:
π Long-term GLP-1 therapy for those living with obesity
π€ Intensive behavioral support to amplify and sustain benefits
But the message is clearβmedication alone is not enough. True progress requires strong health systems, equitable access, and person-centered prevention and care.
A timely call to action for clinicians, policymakers, and health leaders everywhere. π±π